Hayek Kallen Investment Management Novartis Ag Transaction History

Hayek Kallen Investment Management

  • $268 Million
  • Q2 2024

A detailed history of Hayek Kallen Investment Management transactions in Novartis Ag stock. As of the latest transaction made, Hayek Kallen Investment Management holds 40,695 shares of NVS stock, worth $4.71 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares
40,695
Previous 40,965 0.66%
Holding current value
$4.71 Million
Previous $3.96 Million 9.31%
% of portfolio
1.62%
Previous 1.52%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024
SELL
$92.57 - $107.37 $24,993 - $28,989
-270 Reduced 0.66%
40,695 $4.33 Million
Q1 2024

May 03, 2024
BUY
$95.27 - $108.47 $17,148 - $19,524
180 Added 0.44%
40,965 $3.96 Million
Q4 2023

Feb 08, 2024
SELL
$92.27 - $101.54 $12,548 - $13,809
-136 Reduced 0.33%
40,785 $4.12 Million
Q3 2023

Nov 07, 2023
SELL
$94.73 - $105.13 $8,146 - $9,041
-86 Reduced 0.21%
40,921 $4.17 Million
Q2 2023

Aug 11, 2023
BUY
$92.52 - $104.91 $168,293 - $190,831
1,819 Added 4.64%
41,007 $4.14 Million
Q1 2023

May 08, 2023
SELL
$80.03 - $92.81 $92,594 - $107,381
-1,157 Reduced 2.87%
39,188 $3.61 Million
Q4 2022

Feb 09, 2023
SELL
$75.55 - $92.52 $45,330 - $55,512
-600 Reduced 1.47%
40,345 $3.66 Million
Q3 2022

Oct 19, 2022
SELL
$74.61 - $87.26 $7,461 - $8,726
-100 Reduced 0.24%
40,945 $3.11 Million
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $72,468 - $84,375
-900 Reduced 2.15%
41,045 $3.47 Million
Q1 2022

May 09, 2022
SELL
$80.11 - $90.62 $70,096 - $79,292
-875 Reduced 2.04%
41,945 $3.68 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $9,165 - $10,134
-115 Reduced 0.27%
42,820 $3.75 Million
Q3 2021

Oct 06, 2021
SELL
$81.78 - $95.14 $31,730 - $36,914
-388 Reduced 0.9%
42,935 $3.51 Million
Q2 2021

Aug 12, 2021
BUY
$85.24 - $94.15 $10,569 - $11,674
124 Added 0.29%
43,323 $3.95 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $2,171 - $2,560
26 Added 0.06%
43,199 $3.69 Million
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $2,185 - $2,644
-28 Reduced 0.06%
43,173 $4.08 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $18,070 - $20,020
-220 Reduced 0.51%
43,201 $3.76 Million
Q2 2020

Sep 10, 2020
SELL
$80.93 - $91.1 $31,400 - $35,346
-388 Reduced 0.89%
43,421 $3.79 Million
Q1 2020

Apr 22, 2020
SELL
$70.67 - $99.01 $62,118 - $87,029
-879 Reduced 1.97%
43,809 $3.61 Million
Q4 2019

Feb 13, 2020
SELL
$84.35 - $95.37 $13,496 - $15,259
-160 Reduced 0.36%
44,688 $4.23 Million
Q3 2019

Nov 05, 2019
SELL
$85.54 - $94.26 $50,639 - $55,801
-592 Reduced 1.3%
44,848 $3.9 Million
Q2 2019

Jul 17, 2019
SELL
$75.4 - $92.8 $28,275 - $34,800
-375 Reduced 0.82%
45,440 $4.15 Million
Q1 2019

May 09, 2019
SELL
$75.32 - $86.15 $104,016 - $118,973
-1,381 Reduced 2.93%
45,815 $4.41 Million
Q4 2018

Jan 16, 2019
SELL
$73.66 - $82.02 $45,300 - $50,442
-615 Reduced 1.29%
47,196 $4.05 Million
Q3 2018

Nov 09, 2018
SELL
$66.94 - $77.43 $55,091 - $63,724
-823 Reduced 1.69%
47,811 $4.12 Million
Q3 2018

Nov 09, 2018
BUY
$66.94 - $77.43 $55,091 - $63,724
823 Added 1.72%
48,634 $3.93 Million
Q2 2018

Aug 03, 2018
SELL
$64.91 - $73.36 $53,420 - $60,375
-823 Reduced 1.69%
47,811 $3.61 Million
Q1 2018

May 10, 2018
SELL
$70.39 - $84.15 $121,774 - $145,579
-1,730 Reduced 3.43%
48,634 $3.93 Million
Q4 2017

Feb 08, 2018
SELL
$72.33 - $77.64 $37,973 - $40,761
-525 Reduced 1.03%
50,364 $4.23 Million
Q3 2017

Oct 25, 2017
BUY
$74.14 - $77.27 $3.77 Million - $3.93 Million
50,889
50,889 $4.37 Million

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hayek Kallen Investment Management Portfolio

Follow Hayek Kallen Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hayek Kallen Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hayek Kallen Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email